Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2000
10/31/2000CA2204180C Melt-extruded orally administrable therapeutically active formulations
10/31/2000CA2189658C Controlled-release dosage forms of azithromycin
10/31/2000CA2182004C Film coated tablet of paracetamol and domperidone
10/26/2000WO2000063699A1 A tenascin-c isoform as a marker for neoplasias
10/26/2000WO2000063409A1 Endosomolytic agents and cell delivery systems
10/26/2000WO2000063385A2 Nucleic acid immunization
10/26/2000WO2000063364A2 Methods and compositions for inhibiting the function of polynucleotide sequences
10/26/2000WO2000063248A2 Highly purified gonadotropin compositions and process for preparing them
10/26/2000WO2000062814A2 Intracellular pharmaceutical targeting
10/26/2000WO2000062813A2 Cationic peg-lipids and methods of use
10/26/2000WO2000062810A1 An oral formulation for ileum administering comprising an inhibitor compound of the ileal bile acid transport
10/26/2000WO2000062807A1 Diagnosis and treatment of neuroectodermal tumors
10/26/2000WO2000062801A2 Combination vaccine against streptococcus pneumoniae and respiratory syncytial virus (rsv)
10/26/2000WO2000062793A2 Pseudomycin antifungal compositions and methods for their use
10/26/2000WO2000062769A2 Use of ap-1 activators to treat glaucoma and ocular hypertension
10/26/2000WO2000062764A1 Gum pad for delivery of medication to mucosal tissues
10/26/2000WO2000062762A1 Chewing gum with dental benefits including calcium in a food grade acid
10/26/2000WO2000062761A1 Process for microencapsulation of water soluble substances
10/26/2000WO2000062759A1 Dry, mouldable drug formulation
10/26/2000WO2000062757A1 Composition containing opioid antagonists and spray dispenser
10/26/2000WO2000062753A1 Pharmaceutical or cosmetic compositions for the local, intradermal application of hormones
10/26/2000WO2000047607B1 A synthetic peptide disturbing intracellular signaling
10/26/2000WO2000038695A3 Aciclovir compositions containing dimethicone
10/26/2000WO2000037099A3 Method for accelerating the rate of mucociliary clearance by using a kunitz-type serine protease inhibitor
10/26/2000WO2000035441A3 Pharmaceutical aerosol formulations containing fluoroalkanes, budesonide and formoterol
10/26/2000WO2000034444A3 Method and composition for preserving viruses
10/26/2000WO2000031120A3 Hexapeptide with the stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation, differentiation and apoptosis
10/26/2000WO2000026385A9 Nucleic acid constructs for genetic immunization
10/26/2000WO2000019976A9 Biodegradable terephthalate polyester-poly(phosphonate) and polyester-poly(phosphite) compositions, articles, and methods of using them
10/26/2000DE19918627A1 Hybrid polymer composition, useful as drug carrier providing controllable and reproducible release, is obtained by crosslinking water-soluble polymer with titanate or zirconate in presence of silica component
10/26/2000DE19918434A1 Storage-stable solid proton pump inhibitor formulation useful e.g. for treating duodenal ulcers, comprises amorphous active agent embedded in auxiliary matrix
10/26/2000DE19918325A1 Extruded drug dosage form, e.g. granulate for tableting, comprising an active agent in a polysaccharide-containing matrix, giving a release profile which is controllable by extrusion conditions and/or the inclusion of additives
10/26/2000DE19918106A1 Transdermal patches containing basic or neutral drug include adhesive (meth)acrylic acid polymer in alkali(ne earth) metal salt form
10/26/2000DE10017883A1 Neues Behandlungsverfahren New treatment methods
10/26/2000CA2379105A1 An oral formulation for ileum administering comprising an inhibitor compound of the ileal bile acid transport
10/26/2000CA2371942A1 Pseudomycin antifungal compositions and methods for their use
10/26/2000CA2370690A1 Cationic peg-lipids and methods of use
10/26/2000CA2370646A1 Nucleic acid immunization
10/26/2000CA2370628A1 Methods and compositions for inhibiting the function of polynucleotide sequences
10/26/2000CA2370130A1 Chewing gum with dental benefits including calcium in a food grade acid
10/26/2000CA2370004A1 Intracellular pharmaceutical targeting
10/26/2000CA2369808A1 Process for microencapsulation of water soluble substances
10/26/2000CA2369126A1 Use of ap-1 activators to treat glaucoma and ocular hypertension
10/26/2000CA2365579A1 Combination vaccine against streptococcus pneumoniae and respiratory syncytial virus (rsv)
10/25/2000EP1046397A2 Novel bioactivating substance
10/25/2000EP1046393A1 Composition containing at least one bicyclic aromatic compound and at least one 2-alkyl-1-alkanol or an ester, and its use
10/25/2000EP1045897A1 Enzyme catalyzed therapeutic agents
10/25/2000EP1045863A1 Detoxication of active pharmaceutical substances using cyclodextrine oligomers
10/25/2000EP1045861A1 Antibody/receptor targeting moiety for enhanced delivery of armed ligand
10/25/2000EP1045825A1 Novel polyethoxylated castor oil, process of making the same and formulations thereof
10/25/2000EP1045703A1 Stabilization of lipid:dna formulations during nebulization
10/25/2000EP1045700A1 Oral delivery of nucleic acid vaccines by particulate complexes
10/25/2000EP1045699A1 Genetic immunization with co-delivery of nucleic acid and cytokines in a single vehicle
10/25/2000EP1045696A1 Oral oil sorbing composition
10/25/2000EP1045692A1 Skin protection composition
10/25/2000EP1045681A1 METHOD AND COMPOSITIONS FOR $i(IN SITU) FORMATION OF PROTECTIVE AND/OR MEDICATED FILMS ON BODY TISSUE
10/25/2000EP1045637A1 Decorated red blood cells
10/25/2000EP1024790A4 Injectable biodegradable block copolymer gels for use in drug delivery
10/25/2000EP0914042A4 Cluster clearing agents
10/25/2000EP0804088B1 Stabilized composition comprising colistin sulfate
10/25/2000EP0785770B1 Hemorrhoidal compositions and method of use
10/25/2000EP0714418B1 Cosmetic melanins
10/25/2000EP0635218B1 Taste modifying method and bitter taste reducing method
10/25/2000EP0627911B1 Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
10/25/2000EP0601053B1 Compositions and methods for the sublingual or buccal administration of therapeutic agents
10/25/2000CN1271280A A transdermal drug delivery system for anti-inflammatory analogesic agent comprising diclofenac diethylammonium, and the manufacturing method thereof
10/25/2000CN1271277A Biodegradable macromers fro the controlled release of biologically active substances
10/25/2000CN1271276A Controlled release of drugs delivered by sublingual or buccal administration
10/25/2000CN1271251A 2-methyl-thieno-benzodiazepine formulation
10/25/2000CN1270838A Adjuvant used in vaccine
10/25/2000CN1057673C Tablet, capsule, or granule comprising desogestrel
10/25/2000CN1057670C Prolonged release preparation and polymers thereof
10/24/2000US6136956 Fibrous assembly of peptide lipid and method for the preparation thereof
10/24/2000US6136864 Denaturants for sympathomimetic amine salts
10/24/2000US6136846 In water miscible solubilizer
10/24/2000US6136838 Administering by injection
10/24/2000US6136833 Pharmaceutical formulations and process for their preparation
10/24/2000US6136799 Cosolvent formulations
10/24/2000US6136796 Drugs for antiischemic agents, strokes, antiepileptic agents and antiasthma agents
10/24/2000US6136793 Formulations containing hyaluronic acid
10/24/2000US6136788 Pharmaceutical preparation for the therapy of immune deficiency conditions
10/24/2000US6136783 Antifungal compositions
10/24/2000US6136563 With defined substitutions for enhanced affinity for its receptor
10/24/2000US6136357 Anhydrous; cyclosporin; monoglycerides, diglycerides, and/or triglycerides of natural fatty acids; natural fatty acids and/or their alkaline salts; a substance containing 3-sn-phosphatidyl choline and/or phosphatidyl ethanolamine
10/24/2000US6136347 Drug as anhydrate of its base form microencapsulated in a coating of methyl or ethyl esters or quaternary ammonium compounds of polymethacrylic acid, or ethylcellulose, and triethyl citrate, optionally hydroxypropyl methyl cellulose
10/24/2000US6136346 Spray drying an aqueous mixture of an excipient, a dispersibility-enhancing, water soluble polypeptide and drug to obtain an aerosolizable powder for inhalation therapy having increased dispersibility due to the polypeptide
10/24/2000US6136343 Excipient including a gelling agent, an inert pharmaceutical diluent, cationic crosslinking agent with said gelling agent that increases gel strength when dosage form exposed to environmental fluid, and a medicament having poor solubility
10/24/2000US6136337 Comprises an acrylic acid polymer, a vasoconstrictor, and a rectal tissue-curing agent; suppository; for curing hemorrhoids or the like
10/24/2000US6136336 JM216 formulations
10/24/2000US6136332 Dermatological/pharmaceutical compositions comprising volatile oils/phenylated silicone oils
10/24/2000US6136323 Forming immunology response
10/24/2000US6136321 Incubation in a polysorbate
10/24/2000US6136295 Biocompatible particles for delivery of a therapeutic, prophylactic or diagnostic agent to the pulmonary system comprising a therapeutic, prophylactic or diagnostic agent
10/24/2000US6136294 Amino acid stabilized medical aerosol formulation
10/24/2000US6136293 Gas or air filled microbubble suspensions in aqueous phases usable as imaging contrast agents in ultrasonic echography
10/24/2000US6135976 Method, device and kit for performing gene therapy
10/24/2000CA2211376C Bio-erodible ophthalmic shield
10/24/2000CA2194226C Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same
10/24/2000CA2181810C Process for producing s(+)-ibuprofen particles
10/24/2000CA2139664C Covalent polar lipid-peptide conjugates for biological targeting
1 ... 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 ... 1712